Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Virological failure and subsequent resistance profiles in individuals exposed to atazanavir.

Stebbing J, Nathan B, Jones R, McKenna A, Powles T, Bower M, Holmes P, Gazzard B, Nelson M.

AIDS. 2007 Aug 20;21(13):1826-8.

PMID:
17690587
2.

Atazanavir/ritonavir: a review of its use in HIV therapy.

von Hentig N.

Drugs Today (Barc). 2008 Feb;44(2):103-32. doi: 10.1358/dot.2008.44.2.1137107. Review.

PMID:
18389089
3.

Atazanavir: improving the HIV protease inhibitor class.

Becker S.

Expert Rev Anti Infect Ther. 2003 Oct;1(3):403-13. Review.

PMID:
15482137
4.

Atazanavir: a new protease inhibitor to treat HIV infection.

Musial BL, Chojnacki JK, Coleman CI.

Am J Health Syst Pharm. 2004 Jul 1;61(13):1365-74. Review. Erratum in: Am J Health Syst Pharm. 2004 Nov 1;61(21):2243.

PMID:
15287232
5.

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.

Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA.

AIDS. 2009 Jan 28;23(3):279-91. doi: 10.1097/QAD.0b013e32831c54e5. Review.

PMID:
19114854
6.

[Efficacy of atazanavir in simplification regimens].

Zamora L, Gatell JM.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:14-21. doi: 10.1016/S0213-005X(08)76615-1. Review. Spanish.

PMID:
20116612
7.

Review of atazanavir: a novel HIV protease inhibitor.

Fuster D, Clotet B.

Expert Opin Pharmacother. 2005 Aug;6(9):1565-72. Review.

PMID:
16086644
8.

Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients.

Youle M.

J Antimicrob Chemother. 2007 Dec;60(6):1195-205. Epub 2007 Sep 21. Review.

9.

Atazanavir: a novel HIV-1 protease inhibitor.

Piliero PJ.

Expert Opin Investig Drugs. 2002 Sep;11(9):1295-301. Review.

PMID:
12225250
10.

Atazanavir for the treatment of human immunodeficiency virus infection.

Busti AJ, Hall RG, Margolis DM.

Pharmacotherapy. 2004 Dec;24(12):1732-47. Review.

PMID:
15585441
11.

Atazanavir: new option for treatment of HIV infection.

Havlir DV, O'Marro SD.

Clin Infect Dis. 2004 Jun 1;38(11):1599-604. Epub 2004 May 13. Review.

12.

Atazanavir: a review of its use in the management of HIV infection.

Swainston Harrison T, Scott LJ.

Drugs. 2005;65(16):2309-36. Review.

PMID:
16266202
13.

Atazanavir: simplicity and convenience in different scenarios.

Pérez-Elías MJ.

Expert Opin Pharmacother. 2007 Apr;8(5):689-700. Review.

PMID:
17376023
14.

Atazanavir.

Orrick JJ, Steinhart CR.

Ann Pharmacother. 2004 Oct;38(10):1664-74. Epub 2004 Sep 7. Review.

PMID:
15353575
15.

[Lopinavir/ritonavir monotherapy for the treatment of HIV-1 infection: the emergence of resistance].

Delgado R.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:34-40. Review. Spanish.

PMID:
19572443
16.

Atazanavir: its role in HIV treatment.

Wood R.

Expert Rev Anti Infect Ther. 2008 Dec;6(6):785-96. doi: 10.1586/14787210.6.6.785. Review.

17.

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

Chetchotisakd P.

Expert Rev Anti Infect Ther. 2009 Sep;7(7):801-5. doi: 10.1586/eri.09.66. Review.

PMID:
19735222
18.

Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection.

Sahali S, Chaix ML, Delfraissy JF, Ghosn J.

AIDS Rev. 2008 Jan-Mar;10(1):4-14. Review.

PMID:
18385776
19.

[Therapeutic strategies for HIV infection: clinical approach with boost antiproteases in adults].

de Truchis P.

Med Mal Infect. 2004 Nov;34 Suppl 3:S199-204. Review. French.

PMID:
15906442
20.

Tipranavir: a new option for the treatment of drug-resistant HIV infection.

Temesgen Z, Feinberg J.

Clin Infect Dis. 2007 Sep 15;45(6):761-9. Epub 2007 Aug 7. Review.

Items per page

Supplemental Content

Write to the Help Desk